Chapter 22. Lung Cancer in the Elderly

  1. Stephen Jackson Professor of Geriatric Medicine2,
  2. Paul Jansen3 and
  3. Arduino Mangoni4
  1. Jeffrey Bowden

Published Online: 2 APR 2009

DOI: 10.1002/9780470017975.ch22

Prescribing for Elderly Patients

Prescribing for Elderly Patients

How to Cite

Bowden, J. (2009) Lung Cancer in the Elderly, in Prescribing for Elderly Patients (eds S. Jackson, P. Jansen and A. Mangoni), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470017975.ch22

Editor Information

  1. 2

    Department of Clinical Gerontology, King's College Hospital, London, UK

  2. 3

    Department of Geriatric Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands

  3. 4

    Department of Clinical Pharmacology, Flinders University, Flinders Medical Centre, Adelaide, Australia

Author Information

  1. Department of Medicine, Flinders Medical Centre, Adelaide, Australia

Publication History

  1. Published Online: 2 APR 2009
  2. Published Print: 27 MAY 2009

ISBN Information

Print ISBN: 9780470024287

Online ISBN: 9780470017975



  • lung cancer in elderly;
  • chemotherapeutic agents;
  • ECOg performance status*;
  • treatment protocols for NSCLC;
  • surgical resection as primary treatment for stage 1 carcinoma;
  • vinca alkaloids (vincristine, vindesine, vinblastine, vinorelbine);
  • chemotherapy for combined therapy for stage 3A and 3B disease;
  • 1st line therapy for advanced disease - combination therapy;
  • non cytotoxic agents - EGFR inhibitors


This chapter contains sections titled:

  • Introduction

  • Aetiology

  • Symptoms and signs

  • Diagnosis and staging

  • Goals of therapy

  • Chemotherapeutic agents

  • Treatment protocols for NSCLC

  • Non cytotoxic agents: EGFR Inhibitors

  • Treatment of small cell carcinoma

  • Treatment of mesothelioma

  • Anti-emetic therapy

  • Key Points

  • Guidelines

  • References